Cytovale | Latest News & Updates - Dec 11, 2024 Release
Our Lady of the Lake Ascension in Louisiana chose Cytovale to support faster sepsis detection...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡
Cytovale
🌎 cytovale.comCytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Their FDA cleared IntelliSep test analyzes white blood cells to stratify a patient’s risk of sepsis in under 10 minutes, addressing the urgent need for early detection of this lethal condition.
Cytovale - Latest News and Updates
- Our Lady of the Lake Ascension in Louisiana chose Cytovale to support faster sepsis detection.
- Chris Fong, MBA has joined Cytovale as Vice President of Commercial Excellence, previously serving as Senior Director, US Marketing, Rare Disease, Thought Leader Liaison Lead, TTR Franchise at Alnylam Pharmaceuticals.
- Cytovale CEO Ajay Shah will speak about innovation in early sepsis detection at the 13th Annual Forbes Healthcare Summit on December 4, 2024, in New York.
- Cytovale won Inc. Magazine’s 2024 Best In Business award in the Health Products category.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.